Acute Coronary Syndrome Market
According to Intent Market Research, the Acute Coronary Syndrome Market is expected to grow from USD 10.1 billion in 2023 at a CAGR of 6.4% to touch USD 15.7 billion by 2030. The Acute Coronary Syndrome Market is dominated by key players such as, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, and Sanofi.